Regional difference and similarity of familial amyloidosis with polyneuropathy in France

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Amyloid: Journal of Protein Folding Disorders

• Publication date

  2012-05-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/13506129.2012.685665PMID 22620968
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid neuropathy mimicking chronic inflammatory demyelinating polyneuropathy

  2012cited by this paper
• Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy

  2010cited by this paper
• A brief compound test for assessment of autonomic and sensory-motor dysfunction in familial amyloid polyneuropathy

  2007cited by this paper
• The molecular biology and clinical features of amyloid neuropathy

  2007cited by this paper
• Late-onset familial amyloid polyneuropathy: An autopsy study of two Japanese brothers

  2003cited by this paper
• Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form.

  2002cited by this paper
• Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy

  1998cited by this paper
• LIVER TRANSPLANTATION IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY FOLLOW‐UP OF THE FIRST 20 SWEDISH PATIENTS

  1995cited by this paper
• [Demonstration of genetic mutation in most of the amyloid neuropathies with sporadic occurrence].

  1992cited by this paper
• Molecular genetics of amyloid neuropathy in Europe

  1989influential reference
• Molecular genetics of amyloid neuropathy in Europe.

  1989cited by this paper
• Length‐dependent degeneration of fibers in Portuguese amyloid poly neuropathy

  1984cited by this paper
• [Familial amyloid neuropathies in 3 families of French origin].

  1983cited by this paper
• Forty years of experience with type I amyloid neuropathy. Review of 483 cases

  1980influential reference
• A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves.

  1952cited by this paper

• Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Hereditary Transthyretin Amyloidosis Polyneuropathy.

  2026cites this paper
• Genetic testing and evidence of a founder mutation in a hotspot for hereditary transthyretin amyloidosis

  2025cites this paper
• Hereditary transthyretin amyloidosis with polyneuropathy: results of multicenter screening of patients with carpal tunnel syndrome in Russia (LOCUS study)

  2025cites this paper
• Relationship between amyloid choroidopathy and neurological involvement severity scores in transthyretin amyloidosis.

  2025cites this paper
• Prevalence of hereditary transthyretin amyloidosis in CIDP patients with red flags: a multicenter genetic screening and misdiagnosis analysis

  2025cites this paper
• A new screening tool for early recognition of ATTRv polyneuropathy in clinical practice: AmyloScan®

  2025cites this paper
• Hereditary Transthyretin Amyloidosis with Polyneuropathy

  2025cites this paper
• Bulbar Syndrome as Atypical Presentation of Transthyretin Familial Amyloid Neuropathy Associated with First Bite Syndrome: Possible Causal Relationship

  2024cites this paper
• Transthyretin amyloid polyneuropathy in France: A cross-sectional study with 413 patients and real-world tafamidis meglumine use (2009-2019).

  2024cites this paper
• Diagnostic delay in patients with sporadic hereditary transthyretin-mediated amyloidosis

  2024cites this paper
• Electrophysiological Monitoring of Asymptomatic Transthyretin Mutation Carriers

  2024cites this paper
• Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal

  2023cites this paper
• Treatment response and neurofilament light chain levels with long-term patisiran in hereditary transthyretin-mediated amyloidosis with polyneuropathy: 24-month results of an open-label extension study

  2023cites this paper
• Brazilian consensus for diagnosis, management and treatment of hereditary transthyretin amyloidosis with peripheral neuropathy: second edition

  2022cites this paper
• Vitreous involvement as initial presentation of hereditary transthyretin amyloidosis related to the rare TTR Ile107Met (p.Ile127Met) pathogenic variant

  2022cites this paper
• Neuropatie sensitive

  2022cites this paper
• Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients

  2022cites this paper
• Renal amyloidosis: a new time for a complete diagnosis

  2022cites this paper
• Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience

  2022cites this paper
• Transthyretin Variant Amyloidosis with a TTR A97D (p.A117D) Mutation Manifesting Remarkable Asymmetric Neuropathy

  2022cites this paper
• Strategy for genetic analysis in hereditary neuropathy.

  2022cites this paper
• The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis

  2021cites this paper
• Variant transthyretin amyloidosis (ATTRv) polyneuropathy in Greece: a broad overview with a focus on non-endemic unexplored regions of the country.

  2021cites this paper
• Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression

  2021cites this paper
• Prevalence and Outcomes of p.Val142Ile TTR Amyloidosis Cardiomyopathy

  2021cites this paper
• Management of transthyretin amyloidosis.

  2021cites this paper
• Interpreting signals from the peripheral nerve in amyloidosis: a call for action

  2021cites this paper
• Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy

  2020cites this paper
• Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy.

  2020cites this paper
• Conjunctival lymphangiectasia as a biomarker of severe systemic disease in Ser77Tyr hereditary transthyretin amyloidosis

  2020cites this paper
• Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations

  2020cites this paper
• Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner

  2020cites this paper
• ATTRv amyloidosis Italian Registry: clinical and epidemiological data

  2020cites this paper
• Anticipation on age at onset in kindreds with hereditary ATTRV30M amyloidosis from the Majorcan cluster

  2020cites this paper
• Transthyretin Amyloidosis: Testing Strategies And Model for Center of Excellence Support.

  2020cites this paper
• Val50Met hereditary transthyretin amyloidosis: not just a medical problem, but a psychosocial burden

  2020cites this paper
• Acquired and inherited amyloidosis: Knowledge driving patients' care

  2020cites this paper
• Disease modifying therapies for attr amyloidoses: clinical development of new drugs and impact on the natural history of the disease

  2019cites this paper
• Clinicopathological correlations of sural nerve biopsies in TTR Val30Met familial amyloid polyneuropathy

  2019cites this paper
• An Organ System-Based Approach to Differential Diagnosis of Amyloid Type in Surgical Pathology.

  2019cites this paper
• Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease

  2019cites this paper
• Neuropathy Associated with Systemic Amyloidosis

  2019cites this paper
• Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy

  2018cites this paper
• Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial

  2018cites this paper
• Transthyretin-Amyloidose (ATTR-Amyloidose): Empfehlungen zum Management in Deutschland und Österreich

  2018cites this paper
• Morphometric analysis of sural nerve biopsy in Familial Amyloid Polyneuropathy

  2018cites this paper
• Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm

  2018cites this paper
• IDENTIFICATION OF TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY IN NEW COUNTRIES

  2017cites this paper
• Familial amyloid polyneuropathy

  2017cites this paper
• Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis

  2017cites this paper
• AUTOIMMUNITY, ENVIRONMENT AND GENETICS IN INFLAMMATORY DISORDERS OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM

  2017cites this paper
• Clinical variability in late - AO cases of transthyretin related Familiar Amyloid Polyneuropathy diagnosed from 2007 to 2016.

  2017cites this paper
• Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy

  2017cites this paper
• Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis

  2016cites this paper
• Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis

  2016cites this paper
• Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy

  2016cites this paper
• Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP

  2016cites this paper
• First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy

  2016cites this paper
• Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses

  2016cites this paper
• Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment?

  2016cites this paper
• TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies

  2016cites this paper
• Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area

  2015cites this paper
• Rapid progression of familial amyloidotic polyneuropathy

  2015cites this paper
• Transthyretin Asp38Tyr: a new mutation associated to a late onset neuropathy

  2015cites this paper
• Genotype–phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France

  2015cites this paper
• Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.

  2015cites this paper
• Evolving landscape in the management of transthyretin amyloidosis

  2015cites this paper
• Current and future treatment of amyloid neuropathies

  2014influential citation
• Hereditäre Transthyretin-Amyloidosen

  2014cites this paper
• Familial amyloid polyneuropathy: elaboration of a therapeutic patient education programme, “EdAmyl”

  2014cites this paper
• FAP Neuropathy and Emerging Treatments

  2014cites this paper
• Hereditäre Transthyretin-Amyloidosen

  2014cites this paper
• [Use of RNAi in the treatment of hereditary amyloidosis due to mutation of transthyretin].

  2014cites this paper
• An amyotrophic lateral sclerosis-like syndrome revealing an amyloid polyneuropathy associated with a novel transthyretin mutation

  2013cites this paper
• Recent advances in the treatment of familial amyloid polyneuropathy

  2013cites this paper
• Familiárna amyloidná polyneuropatia

  2013cites this paper
• Investigations complémentaires devant une neuropathie périphérique

  2013cites this paper
• [Current issues in hereditary neuropathies].

  2013cites this paper
• Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy

  2013cites this paper
• What is the prototype of familial amyloid polyneuropathy?

  2013cites this paper
• [Familial amyloidotic polyneuropathies].

  2012cites this paper
• Amyloid neuropathies.

  2012cites this paper
• [Familial amyloid polyneuropathies: therapeutic issues].

  2012cites this paper
• Neuropathies amyloïdes héréditaires: aspects thérapeutiques.

  2012cites this paper
• Transthyretin‐related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset

  2012cites this paper
• Neuropathies amyloïdes héréditaires: aspects cliniques et neuropathologiques

  2012cites this paper